Ecopharmacovigilance: Perspectives, concepts, applications, and relationships in modern context
Environmental scientists have made great strides to regulate pharmaceutical waste. However, the monitoring of emerged environmental problems induced by drugs should attract further interest of pharmacy and pharmacovigilance scientists. Ecopharmacovigilance (EPV) as a kind of pharmacovigilance for the atmosphere is widely recognized as essential to minimize the environmental impact of pharmaceutical toxins. In efforts to answer the environmental issues created by medications, the constructive involvement of the pharmaceutical sector is essential. In a prioritized basis, EPV can target individual pharmaceuticals. For EPV deployment targeting pharmaceutical contamination, certain advice and management practice solutions are recommended. On administration certain drugs are metabolized throughout the bloodstream, being inert or becoming converted to metabolites, whereas others are excreted in the urine or liver and excreted in the sewage. The substances that are released into drainage can be processed into a number of chemicals by a sewage treatment process. The involvement of different drugs and their components has been found in the marine world, with the aquatic environment being the most researched to-date. Nanostructure materials have been around for a long time, and its interactions with biological processes have been discussed in various applications to enhance the understanding and importance of environmental and health effects. In order to regulate pharmaceutical residues in effluents, Technologies for sewage water management should be applied. In particular, the presence of pharmacy including pharmacovigilance professionals is also important for enhancing multidisciplinary collaboration.
Camacho-Munoz D, Martín J, Santos JL, Alonso E, Aparicio I, De la Torre T, Rodriguez C, Malfeito JJ. Effectiveness of three configurations of membrane bioreactors on the removal of priority and emergent organic compounds from wastewater: comparison with conventional wastewater treatments. Journal of Environmental Monitoring, 2012;14(5):1428-36.
Cerro-Lopez M, Méndez-Rojas MA. Application of nanomaterials for treatment of wastewater containing pharmaceuticals. In: Ecopharmacovigilance. 2017 (pp. 201-219). Springer, Cham.
Coetsier C, Lin L, Roig B, Touraud E. Integrated approach to the problem of pharmaceutical products in the environment: An overview. Analytical and Bioanalytical Chemistry, 2007;387(4):1163-6.
Gomez-Olivan LM, editor. Ecopharmacovigilance: Multidisciplinary Approaches to Environmental Safety of Medicines. Springer; 2018.
Gupta YK. Ensuring patient safety-launching the new pharmacovigilance programme of India. Pharma Times, 2010;42(8):21-6.
Halling-Sorensen BN, Nielsen SN, Lanzky PF, Ingerslev F, Lutzhoft HH, Jorgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere, 1998;36(2):357- 93.
He BS, Wang J, Liu J, Hu XM. Eco-pharmacovigilance of non-steroidal anti-inflammatory drugs: necessity and opportunities. Chemosphere, 2017;181:178-89.
Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P. Implementing ecopharmacovigilance in practice: challenges and potential opportunities. Drug Safety, 2013;36(7):533-46.
Islas-Flores H, Gomez-Olivan LM, SanJuan-Reyes N, Elizalde-Velázquez A, Dublan-Garcia O, Galar- Martinez M, Garcia-Medina S, Hernandez-Navarro MD. Background to the Emergence of Ecopharmacovigilance. In: Ecopharmacovigilance. 2017 (pp. 13-20). Springer, Cham.
Jones OA, Voulvoulis N, Lester JN. Human pharmaceuticals in the aquatic environment a review. Environmental Technology, 2001;22(12):1383-94.
Kharisov BI, Kharissova OV, Ortiz-Mendez U, editors. CRC concise encyclopedia of nanotechnology. CRC Press; 2016.
Kümmerer K. Significance of antibiotics in the environment. Journal of Antimicrobial Chemotherapy, 2003;52(1):5-7.
Kuspis DA, Krenzelok EP. What happens to expired medications? A survey of community medication disposal. Veterinary and Human Toxicology, 1996;38(1):48-9.
Medhi B, Sewal RK. Ecopharmacovigilance: An issue urgently to be addressed. Indian Journal of Pharmacology, 2012;44(5):547-9.
Méndez-Rojas MA, Sánchez-Salas JL, Angulo-Molina A, Palacios-Hernández TD. Environmental risks of nanotechnology: evaluating the ecotoxicity of nanomaterials. Nanomaterials for Environmental Protection. John Wiley & Sons, Hoboken, NJ. 2014:503-17.
Nieto A, Borrull F, Pocurull E, Marcé RM. Occurrence of pharmaceuticals and hormones in sewage sludge. Environmental Toxicology and Chemistry, 2010;29(7):1484-9.
Patneedi CB, Prasadu KD. Impact of pharmaceutical wastes on human life and environment. Rasayan Journal of Chemistry, 2015;8(1):67-70.
Rodil R, Quintana JB, Concha-Graña E, López-Mahía P, Muniategui-Lorenzo S, Prada-Rodríguez D. Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere, 2012;86(10):1040- 9.
Silva LJ, Lino CM, Meisel L, Barceló D, Pena A. Ecopharmacovigilance. In: Emerging organic contaminants and human health. 2011 (pp. 213-241); Springer, Berlin, Heidelberg.
Swan GE, Cuthbert R, Quevedo M, Green RE, Pain DJ, Bartels P, Cunningham AA, Duncan N, Meharg AA, Lindsay Oaks J, Parry-Jones J. Toxicity of diclofenac to Gyps vultures. Biology Letters, 2006;2(2):279-82.
Velo G. Ecopharmacovigilance. In: Pharmacovigilance; 2017 (pp. 195-205). Adis, Cham.
Wang J, Hu X. Ecopharmacovigilance: Current state, challenges, and opportunities in China. Indian Journal of Pharmacology, 2014;46(1):13-7.
Wang J, Zhang MY, Liu J, Hu XM, He BS. Using a targeted ecopharmacovigilance intervention to control antibiotic pollution in a rural aquatic environment. Science of the Total Environment. 2019;696:134007.
Copyright (c) 2021 Prachi Khamkar, Debarshi Kar Mahapatra, Atul Kadam
This work is licensed under a Creative Commons Attribution 4.0 International License.